1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 24 AUGUST 2015

Cancer Drug News 24 AUGUST 2015

  • August 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Intensifying Early Access Climate Requires Companies To Be Proactive
Industry Brief - PharmaMar/STA Sign Aplidin Licensing Deal In Australia/New Zealand
Industry Brief - BioLineRx Initiates BL-8040 Phase IIb Trial In AML
Industry Brief - Adcetris Receives Regular FDA Approval For Classical HL Following HSCT
Industry Trend Analysis - Velcade Successor Will Face Tougher Market Environment
Industry Brief - Syndax Raises Funds To Support Entinostat Development
Industry Brief - MTG-201 Gains FDA ODD For Malignant Mesothelioma
Industry Brief - CHMP Issues Positive Opinion On Giotrif Label Update
Industry Brief - Telesta Therapeutics Closes USD28.6mn Private Placement
Industry Brief - Dosing Begins In MVI-816/Keytruda Combination Trial For PCA
Industry Brief - Spectrum/FDA Reach SPA Agreement On Apaziquone Phase III Trial In NMIBC
Industry Brief - Axalimogene Filolisbac/Durvalumab Combination Trial Begins In HPV-Associated Cancers
Industry Brief - FDA Grants Breakthrough Therapy Designation To Exelixis' Cabozantinib For Advanced RCC
Industry Brief - Dosing Begins In VBL's VB-111 Phase III Trial In rGBM
Industry Brief - Orbus Raises Funds To Advance Eflornithine In Recurrent Anaplastic Astrocytoma
Industry Trend Analysis - Limited Options Create Favourable Market Environment For Novartis' Odomzo
Industry Brief - FDA Grants Priority Review For Keytruda In First-Line Advanced Melanoma
Industry Brief - NMT Pharma/CAO Pharma Sign CZ-48 Worldwide Licensing Deal
Industry Brief - AstraZeneca/Peregrine Enter Immuno-Oncology Trial Collaboration
Industry Trend Analysis - Liquid Biopsy/Genomic Data Combination Will Improve Drug Development
Industry Brief - R-Pharm Acquires Ixempra From BMS; Launches US Commercial Operations
Industry Brief - Cancer Conferences - October 2015

Table Of Contents

Cancer Drug News 24 AUGUST 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 10 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6 650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • October 2016
  • Cancer  


    Brain Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in Canada

  • October 2016
    11 pages
  • Cancer  

  • Canada  

    North America  

View report >

Pap Smear Industry in South Africa

  • October 2016
    14 pages
  • Pap Smear  

    Cervical Cancer  

  • South Africa  

View report >


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.